Search bioRxiv⌕ Search

Biology subjects

Tripp, A.

Publications and source records attributed to Tripp, A..

2 recordsLinked to original sources

Computational design of highly active de novo enzymes

Enzymes are broadly used as biocatalysts in industry and medicine due to their coverage of vast areas of chemical space, their exquisite selectivity and efficiency as well as the mild reaction conditions at which they operate. Custom designed enzymes can produce tailor-made biocatalysts with potential applications extending beyond natural reactions. However, current design methods require testing of high numbers of designs and mostly produce de novo enzymes with low catalytic activities. As a result, they require costly experimental optimization and high-throughput screening to be industrially viable. Here we present rotamer inverted fragment finder-diffusion (Riff-Diff), a hybrid machine learning and atomistic modelling strategy for scaffolding catalytic arrays in de novo proteins. We highlight the general applicability of Riff-Diff by designing enzymes for two mechanistically distinct chemical transformations, the retro-aldol reaction and the Morita-Baylis-Hillman reaction. We show that in both cases it is possible to generate catalysts exhibiting activities rivalling those optimized by in-vitro evolution, along with exquisite stereoselectivity. High resolution structures of six of the designs revealed an angstrom level of active site design precision. The design strategy can, in principle, be applied to any catalytically competent amino acid constellation. These findings enable the practical applicability of de novo protein catalysts in synthesis and shed light on fundamental principles of protein design and enzyme catalysis.

biochemistry↗

An Nav1.5-dependent feedback mechanism driving glycolytic acidification in breast cancer metastasis

Solid tumours have abnormally high intracellular [Na+]. The activity of various Na+ channels may underlie this Na+ accumulation. Voltage-gated Na+ channels (VGSCs) have been shown to be functionally active in cancer cell lines, where they promote invasion. However, the mechanisms involved, and clinical relevance, are incompletely understood. Here, we show that protein expression of the Nav1.5 VGSC subtype strongly correlates with increased metastasis and shortened cancer-specific survival in breast cancer patients. In addition, VGSCs are functionally active in patient-derived breast tumour cells, cell lines, and cancer-associated fibroblasts. Knock down of Nav1.5 in a mouse model of breast cancer suppresses expression of invasion-regulating genes. Nav1.5 activity increases glycolysis in breast cancer cells, likely by up-regulating activity of the Na+/K+ ATPase, thus promoting H+ production and extracellular acidification. The pH of murine xenograft tumours is lower at the periphery than in the core, in regions of higher proliferation and lower apoptosis. In turn, acidic extracellular pH elevates persistent Na+ influx through Nav1.5 into breast cancer cells. Together, these findings show positive feedback between extracellular acidification and movement of Na+ into cancer cells which can facilitate invasion. These results highlight the clinical significance of Nav1.5 activity as a potentiator of breast cancer metastasis and provide further evidence supporting the use of VGSC inhibitors in cancer treatment.

cancer biology↗